SHERRY SIEGELMAN: Open Payments
NPI 1861062259 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 21 payments from 8 companies in 2025. Trend: 2023 $573 · 2024 $793 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $146 |
| Axsome Therapeutics, Inc. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, Jornay PM, XIFAXAN, ARISTADA, Korlym.
Industry payments across KY — which companies pay providers there.
